Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on Oscar Health, Lowers Price Target to $9

Morgan Stanley analyst Ricky Goldwasser maintains Oscar Health (NYSE:OSCR) with a Overweight and lowers the price target from $12 to $9.
byBenzinga Newsdesk
September 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Ricky Goldwasser maintains Oscar Health (NYSE:OSCR) with a Overweight and lowers the price target from $12 to $9.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

International Flavors & Fragrances Announced Late Wednesday It Invests $30M To Expand Regional Footprint In Singapore; New Innovation Center And Singapore Flexiblend Plant To Accelerate Innovation And Broaden Co-creation Capabilities In Greater Asia

By Benzinga Newsdesk
October 13, 1:17 AM
New innovation center and Singapore Flexiblend plant to accelerate innovation and broaden co-creation capabilities in Greater Asia IFF (NYSE:IFF) today announced the opening of its new Singapore Innovation Center, the

IFF